Birgitte Volck
Director/Board Member bei SOLENO THERAPEUTICS, INC.
Vermögen: 301 526 $ am 31.03.2024
Profil
Gegenwärtig ist Birgitte Volck SVP, Head-Clinical Development & Medical Affairs bei Ascendis Pharma A. Dr. Volck ist außerdem Mitglied des Vorstands von Soleno Therapeutics, Inc. und Vaccibody AS. Zuvor war Dr. Volck Leiterin der Forschung und Entwicklung bei GlaxoSmithKline Plc, Chief Medical Officer & Senior VP-Development bei Swedish Orphan Biovitrum AB, President-Research & Development bei Avrobio, Inc, Director-Executive Development bei Amgen, Inc, Director-Nordic Medical & Project Director bei Genzyme Danmark und Head-Clinical Development & Medical Affairs bei Pharmexa A. Birgitte Volck promovierte an der Universität von Kopenhagen.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SOLENO THERAPEUTICS INC
0,02% | 26.05.2023 | 7 045 ( 0,02% ) | 301 526 $ | 31.03.2024 |
Aktive Positionen von Birgitte Volck
| Unternehmen | Position | Beginn |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Director/Board Member | 10.06.2019 |
| NYKODE THERAPEUTICS | Director/Board Member | 05.05.2021 |
Ehemalige bekannte Positionen von Birgitte Volck
| Unternehmen | Position | Ende |
|---|---|---|
| ASCENDIS PHARMA A/S | Chief Tech/Sci/R&D Officer | 01.12.2023 |
| AVROBIO, INC. | Chief Tech/Sci/R&D Officer | 01.10.2020 |
TFS Trial Form Support AB
 TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Director/Board Member | 01.01.2020 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 01.08.2018 |
| WILSON THERAPEUTICS AB | Director/Board Member | 01.05.2018 |
Ausbildung von Birgitte Volck
| University of Copenhagen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 7 |
|---|---|
| AMGEN INC. | Health Technology |
| SOLENO THERAPEUTICS, INC. | Health Technology |
| GSK PLC | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| NYKODE THERAPEUTICS | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| AVROBIO, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Pharmexa A/S
 Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Health Technology |
TFS Trial Form Support AB
TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Commercial Services |
TFS Trial Form Support International AB
 TFS Trial Form Support International AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support International AB provides clinical contract research services. It offers clinical development planning, regulatory affairs, medical informatics, study and site coordination, clinical data management, biostatistics, medical writing, and other functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lud, Sweden. | Commercial Services |
| Genzyme Danmark | |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Wilson Therapeutics AB engages in the development of novel therapies for patients with rare copper-mediated disorders. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden. | Health Technology |
